BioCentury | Oct 14, 2013
Company News

Oncoceutics, Calvert Research LLC deal

...Oncoceutics and investment firm Calvert will utilize Calvert's CRO affiliate, Calvert Laboratories Inc., to complete preclinical...
...Calvert did not disclose deal specifics but said its partnerships are generally structured so that Calvert...
...ONC201 has shown anti-tumor effects in mouse models for brain, colon, breast and lung cancers. Calvert...
BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...Medical Partners and Canaan Partners. New investor First Analysis joined existing investors Cahn Medical Technologies; Calvert...
BioCentury | Oct 8, 2001
Finance

Ebb & Flow

...going to the life sciences, alternative energy, education and environmental sectors. Limited partners include the Calvert...
BioCentury | Oct 16, 2000
Regulation

Opening the door to off-patent biologics

...Pharmaceutical Reform Act of 2000" (H.R. 5231), sponsored by Reps. Alan Mollohan (D-W.Va.) and Ken Calvert...
BioCentury | Nov 18, 1996
Emerging Company Profile

Advanced Therapies Inc.

...Therapy Inc. (Sandoz) University collaborators: None Number of employees: 9 Funds raised: $1.7 million Investors: Calvert...
Items per page:
1 - 5 of 5
BioCentury | Oct 14, 2013
Company News

Oncoceutics, Calvert Research LLC deal

...Oncoceutics and investment firm Calvert will utilize Calvert's CRO affiliate, Calvert Laboratories Inc., to complete preclinical...
...Calvert did not disclose deal specifics but said its partnerships are generally structured so that Calvert...
...ONC201 has shown anti-tumor effects in mouse models for brain, colon, breast and lung cancers. Calvert...
BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...Medical Partners and Canaan Partners. New investor First Analysis joined existing investors Cahn Medical Technologies; Calvert...
BioCentury | Oct 8, 2001
Finance

Ebb & Flow

...going to the life sciences, alternative energy, education and environmental sectors. Limited partners include the Calvert...
BioCentury | Oct 16, 2000
Regulation

Opening the door to off-patent biologics

...Pharmaceutical Reform Act of 2000" (H.R. 5231), sponsored by Reps. Alan Mollohan (D-W.Va.) and Ken Calvert...
BioCentury | Nov 18, 1996
Emerging Company Profile

Advanced Therapies Inc.

...Therapy Inc. (Sandoz) University collaborators: None Number of employees: 9 Funds raised: $1.7 million Investors: Calvert...
Items per page:
1 - 5 of 5